HTFL Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

5 Analyst Rating

Wall Street analysts forecast HTFL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HTFL is 38.60 USD with a low forecast of 35.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 26.135

Low

35.00

Averages

38.60

High

40.00

Current: 26.135

Low

35.00

Averages

38.60

High

40.00

Canaccord

Buy

maintain

$39 -> $40

2025-11-13

Reason

Canaccord

Price Target

$39 -> $40

2025-11-13

maintain

Buy

Reason

Canaccord raised the firm's price target on Heartflow to $40 from $39 and keeps a Buy rating on the shares. The firm said HeartFlow delivered a strong Q3/25 beat fresh out of the IPO gate and formally issued guidance ahead of estimates, but very conservative.

JPMorgan

Robbie Marcus

Overweight

maintain

$36 -> $40

2025-11-13

Reason

JPMorgan

Robbie Marcus

Price Target

$36 -> $40

2025-11-13

maintain

Overweight

Reason

JPMorgan analyst Robbie Marcus raised the firm's price target on Heartflow to $40 from $36 and keeps an Overweight rating on the shares. The firm views the company's Q3 report as strong.

Stifel

Buy

maintain

$35 -> $40

2025-11-13

Reason

Stifel

Price Target

$35 -> $40

2025-11-13

maintain

Buy

Reason

Stifel raised the firm's price target on Heartflow to $40 from $35 and keeps a Buy rating on the shares. Following "an excellent quarter for Heartflow," the firm is inclined to view the company's implied Q4 revenue number as "prudent conservatism with just one quarter now reported as a public company," the analyst tells investors in a post-earnings note.

Canaccord

Buy

maintain

$35 -> $39

2025-09-22

Reason

Canaccord

Price Target

$35 -> $39

2025-09-22

maintain

Buy

Reason

Canaccord raised the firm's price target on Heartflow to $39 from $35 and keeps a Buy rating on the shares. The firm updated its model following the release of its 10-Q and itsnew target reflects multiple expansion of the Elite Med-Tech comp group.

JPMorgan

Robbie Marcus

Overweight

initiated

$36

2025-09-02

Reason

JPMorgan

Robbie Marcus

Price Target

$36

2025-09-02

initiated

Overweight

Reason

JPMorgan analyst Robbie Marcus initiated coverage of Heartflow with an Overweight rating and $36 price target. The firm believes Heartflow is one of the "clearest and most pioneering downstream beneficiaries" of the artificial intelligence revolution in the healthcare sector. The company offers regulated healthcare and technology through its AI-enabled, diagnostic software for coronary artery disease, the analyst tells investors in a research note. JPMorgan says the company benefits from a capital-light business model with an "excellent" gross margin profile.

Piper Sandler

Matt O'Brien

Overweight

initiated

$38

2025-09-02

Reason

Piper Sandler

Matt O'Brien

Price Target

$38

2025-09-02

initiated

Overweight

Reason

Piper Sandler analyst Matt O'Brien initiated coverage of Heartflow with an Overweight rating and $38 price target. Heartflow is a commercial-stage medical technology company that provides artificial intelligence-powered software to diagnose and guide the treatment of coronary artery disease, the analyst tells investors in a research note. The firm believes the company remains in the early launch stages of the $2.9B plaque analysis market and is well positioned for continued share gains.

Valuation Metrics

The current forward P/E ratio for Heartflow Inc (HTFL.O) is -44.75, compared to its 5-year average forward P/E of -51.83. For a more detailed relative valuation and DCF analysis to assess Heartflow Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-51.83

Current PE

-44.75

Overvalued PE

-41.84

Undervalued PE

-61.81

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-63.83

Current EV/EBITDA

-39.47

Overvalued EV/EBITDA

-47.71

Undervalued EV/EBITDA

-79.95

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

13.86

Current PS

11.28

Overvalued PS

16.31

Undervalued PS

11.41

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

HTFL News & Events

Events Timeline

No data

News

7.5

12-12PRnewswire

Ventripoint Partners with Nisg̱a'a to Advance Cardiac Imaging in Remote Communities

7.5

12-12Newsfilter

Ventripoint Partners with Nisg̱a'a for Advanced Cardiac Imaging

3.5

12-11Newsfilter

Heartflow Unveils FFRCT Study Results, Saving $33.45 Million in Healthcare Costs

People Also Watch

Frequently Asked Questions

What is Heartflow Inc (HTFL) stock price today?

The current price of HTFL is 26.135 USD — it has decreased -1.3 % in the last trading day.

What is Heartflow Inc (HTFL)'s business?

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

What is the price predicton of HTFL Stock?

What is Heartflow Inc (HTFL)'s revenue for the last quarter?

Heartflow Inc revenue for the last quarter amounts to 46.28M USD, increased 40.51 % YoY.

What is Heartflow Inc (HTFL)'s earnings per share (EPS) for the last quarter?

Heartflow Inc. EPS for the last quarter amounts to -1.04 USD, increased 333.33 % YoY.

What changes have occurred in the market's expectations for Heartflow Inc (HTFL)'s fundamentals?

The market is revising Upward the revenue expectations for HeartFlow, Inc. (HTFL) for FY2025, with the revenue forecasts being adjusted by 4.34% over the past three months. During the same period, the stock price has changed by -20.54%.

How many employees does Heartflow Inc (HTFL). have?

Heartflow Inc (HTFL) has 699 emplpoyees as of December 15 2025.

What is Heartflow Inc (HTFL) market cap?

Today HTFL has the market capitalization of 2.26B USD.